Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

MENTORING Addressing malnutrition and metabolic health in non-communicable diseases through precision Nutrition: impact in quality of life and prognosis of lung cancer patients.

Coordinator
Fundación Imdea Nutrición, Spain
Runs
1 September 2024 to 31 August 2028
Status
Running
EU funding
€4.0m
Total cost
€4.0m
Partners
7 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101162297

What the project is doing

In the project's own words, from its summary on CORDIS.

Malnutrition represents a major burden for a large part of the population and, in particular, for vulnerable population groups like lung cancer patients. Lung cancer is a global health crisis, with over 2.2 million new cases in 2020 and profound societal and economic impacts. Lung cancer patients suffer from reduced quality of life, psychological distress, comorbidities, and the challenges of frequent treatments, as well as malnutrition and metabolic complications.

MENTORING seeks to enhance patients' nutritional and metabolic statuses by targeting deficiencies in macro- and micronutrients and restoring the microbiome and glycomic health profiles. This will contribute to improving the overall quality of life of lung cancer patients, increasing treatment efficacy, and potentially enhancing their survival rates. By combining dietary assessment, nutritional and clinical biomarkers, immune-inflammatory signatures, anthropometry, genetics, glycomics, lung and gut microbiome, and food-related metabolomics, we will develop holistic models able to predict individual responses to personalised dietary plans considering multiple nutritional and metabolic outcomes.

This precision nutrition approach will play a critical role in lung cancer care by customising dietary guidance based on an individual's genetic makeup, nutritional assessment, and health status to reduce cancer progression and increase quality of life. This collaborative effort is tailored to the specific needs of Lung cancer patients, but it has been built in order to make it easily translatable to any other vulnerable population suffering from malnutrition or metabolic impairments.

The ultimate goal of MENTORING is to enhance patients' nutritional and metabolic statuses by using validated multi-omics approaches, potentially transforming the healthcare landscape.

Who is involved

OrganisationCityCountryRole
Fundación Imdea NutriciónMadridSpainCoordinator
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyParticipant
Fundacion Para La Investigacion E Innovacion Biomedica Del Hu Infanta Sofia Y Del HenaresMadridSpainThird party
Servicio Madrileno De SaludMadridSpainParticipant
Universita Degli Studi Di ParmaParmaItalyParticipant
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do PortoPortoPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI